Speaking about the real fund results, this VC is 20 percentage points more often commits exit comparing to other organizations. Comparing to the other companies, this COM Investments performs on 11 percentage points more the average number of lead investments. The fund is constantly included in less than 2 investment rounds annually. The high activity for fund was in 2003. The increased amount of exits for fund were in 2018. The usual things for fund are deals in the range of 10 - 50 millions dollars.
The usual cause for the fund is to invest in rounds with 6 partakers. Despite the COM Investments, startups are often financed by Ignition Partners, Eastven Ericsson Venture Partners, VantagePoint Capital Partners. The meaningful sponsors for the fund in investment in the same round are VantagePoint Capital Partners, Nextel Communications, Innovacom. In the next rounds fund is usually obtained by Ignition Partners, Eastven Ericsson Venture Partners, VantagePoint Capital Partners.
Moreover, a startup needs to be at the age of 4-5 years to get the investment from the fund. We can highlight the next thriving fund investment areas, such as Health Care, VoIP. Among the various public portfolio startups of the fund, we may underline RadioFrame, NextNet Wireless, UNITY Biotechnology
Besides them, we counted 1 critical employee of this fund in our database.
Related Funds
Funds with similar focus
Notable deals
Company | Industry | Round Size | Date | Investors | Location |
UNITY Biotechnology | $35M | 17 Aug 2017 | California, United States | ||
$4M | 01 Dec 2000 | Dublin, County Dublin, Ireland |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Latest deals
Company | Industry | Round Size | Date | Investors | Location |
UNITY Biotechnology | $35M | 17 Aug 2017 | California, United States | ||
$4M | 01 Dec 2000 | Dublin, County Dublin, Ireland |